Evidence-based vs. Evidence-informed Treatments: Understanding the Difference for Mental Health and Substance Use Disorders | Magellan Health Insights

Woman in library standing by bookshelf reading a book | Magellan Healthcare

Evidence-based vs. Evidence-informed Treatments: Understanding the Difference for Mental Health and Substance Use Disorders

by Steven E. Pratt, MD

May 2, 2023 acceptance and commitment therapy, ACT, Anxiety, CBT, chronic pain, Cognitive Behavioral Therapy, ComfortAble®, DBT, DCBT, Depression, dialectical behavior therapy, Digital Cognitive Behavioral Therapy, drugs, EDMR, ERP, esketamine, Evidence-based, evidence-informed, exposure and response prevention therapy, eye movement desensitization and reprocessing therapy, FearFighter®, fluoxetine, Insomnia, intervention, Magellan Federal, Magellan Health, Magellan Healthcare, medication, mental health and wellness apps, MoodCalmer, pregabalin, psychotropic, RDx, response disequilibrium therapy, RESTORE, risperidone, Schizophrenia, SHADE, sleep difficulties, Substance use disorder, TMS, transcranial magnetic stimulation, treatment

Magellan in the News

Digital Mental Health Care Increase Access and Deliver Positive Outcomes

by Magellan Health Insights

May 8, 2018 AJMC, American Journal of Managed Care, American Psychiatric Association, American Psychiatric Association 2018 Annual Meeting, APA, APA 2018 Annual Meeting, CCBT, Cobalt, DCBT, Digital Cognitive Behavioral Therapy, Digital healthcare, Future of Healthcare, healthcare innovation, Magellan, Magellan Health, Magellan Healthcare, Magellan in the News, Magellan RX, RESTORE, Seth Feuerstein